Evidence map›Paper›PMID 41510151›Full record

ArticleTheranostics2026

Enhanced formation of tertiary lymphoid structures shapes the anti-tumor microenvironment in gastrointestinal stromal tumors after imatinib targeted therapy.

Ping Tao, Jiongyuan Wang, Peidang Fan, Wenshuai Liu, Weiqi Lu, Yujie Hu, Qun Lu, Lijie Ma, Hanxing Tong, Yong Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. IGF2-associated tumor cells and APOE-positive macrophages define an imatinib resistance-associated niche in gastrointestinal stromal tumors.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ping TaoDepartment of Laboratory Medicine, Shanghai Traditional Chinese Medicine-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Jiongyuan WangDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Peidang FanDepartment of General Surgery, Shanghai Xuhui Central Hospital, Shanghai, China.
Wenshuai LiuDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Weiqi LuDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Yujie HuDepartment of Laboratory Medicine, Shanghai Traditional Chinese Medicine-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Qun LuDepartment of Laboratory Medicine, Shanghai Traditional Chinese Medicine-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Lijie MaDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Hanxing TongDepartment of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Yong ZhangDepartment of General Surgery, Xiamen Hospital, Zhongshan Hospital, Fudan University, Xiamen, China; Xiamen Clinical Research Centre for Cancer Therapy, Xiamen, China; Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gastrointestinal NeoplasmsGastrointestinal Stromal TumorsImatinib MesylateTertiary Lymphoid StructuresTumor MicroenvironmentAntineoplastic AgentsB-LymphocytesChemokine CXCL12FemaleHumansPrognosisReceptors, CXCR4Tumor-Associated MacrophagesAntineoplastic AgentsChemokine CXCL12Imatinib MesylateReceptors, CXCR4GISTGIST immune classesimatinibsingle-cell RNA sequencingTLS

Identifiers

PMID41510151
PMCPMC12775820

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.